-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Seelos Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2013 to Q2 2024.
- Seelos Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 2.52M shares, a 358% increase year-over-year.
- Seelos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.9M shares, a 38.2% increase from 2022.
- Seelos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.55M shares, a 96.1% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)